title: Pulmonary thromboendarterectomy after treatment with treprostenil in a chronic thromboembolic pulmonary hypertension patient: a case report.
abstract: In recent years, there has been a major advance in the treatment of pulmonary hypertension. New medications are continually added to the therapeutic arsenal. The prostanoids are among the first agents used to treat pulmonary hypertension and are currently considered the most effective. This case study describes a 63-year-old man who was diagnosed with chronic thromboembolic pulmonary hypertension and successfully treated with subcutaneously administered treprostenil for 6 months before a successful pulmonary thromboendarterectomy. Treatment of chronic thromboembolic pulmonary hypertension often requires a multidisciplinary approach before surgery. Further evaluation of prostanoids is needed to define their role and time of initiation of medical therapy in these patients.
authors: Pulmonary Department, "G Papanikolaou" General Hospital, Aristotle University of Thessaloniki, Greece.
authors: Konstantinos
authors: K
authors: Porpodis
authors: Maria
authors: M
authors: Konoglou
authors: Paul
authors: P
authors: Zarogoulidis
authors: Evangelos
authors: E
authors: Kaimakamis
authors: Theodoros
authors: T
authors: Kontakiotis
authors: Despoina
authors: D
authors: Papakosta
authors: Vasilis
authors: V
authors: Zervas
authors: Nikolaos
authors: N
authors: Katsikogiannis
authors: Nikolaos
authors: N
authors: Courcoutsakis
authors: Alexandros
authors: A
authors: Mitrakas
authors: Panagiotis
authors: P
authors: Touzopoulos
authors: Michael
authors: M
authors: Karanikas
authors: Konstantinos
authors: K
authors: Zarogoulidis
authors: Aikaterini
authors: A
authors: Markopoulou